Αποτελέσματα Αναζήτησης
A Good Review Practice, or GRP, is a “documented best practice” within CDER that discusses any aspect related to the process, format, content and/or management of a product review.
Vertical Format: Click here for a high-resolution, printable PDF (3.9 MB) of the infographic. Drug Review Steps Simplified. Preclinical (animal) testing. An investigational new drug...
Conduct Review of New Drug Application (NDA) or Biologics License Application (BLA) The review process takes place in six major steps. Each step will be described in detail later in this...
Our enhanced FDA calendar integrates PDUFA dates, clinical trial primary completion dates, and working capital runway estimates into a single timeline that covers companies publicly traded in the U.S. facing upcoming PDUFA dates.
Purpose of an NDA. Enables FDA to determine: Whether the drug is safe and effective for the proposed indication, and whether the drug’s benefits outweigh the risks. Whether the drug’s proposed labeling is appropriate, and what should be included in the package insert.
CDER 21st Century Review. A six-step process that involves teamwork and collaboration across disciplines for better and more efficient management of the review process. Click on each image to...
These templates are designed to help meet requirements for FDA-regulated clinical trials. They may be useful, but not required, to organize study documentation for other studies as well. Please customize the templates to match your study-specific requirements.